Truist Securities Reiterates Buy on Progyny, Maintains $46 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh has reiterated a Buy rating on Progyny (NASDAQ:PGNY) and maintained a $46 price target.
April 17, 2024 | 5:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities reaffirms a Buy rating on Progyny with a $46 price target, indicating a positive outlook on the stock.
The reiteration of a Buy rating and maintenance of a $46 price target by a reputable analyst like Jailendra Singh from Truist Securities suggests a strong conviction in Progyny's future performance. This endorsement is likely to instill confidence among investors, potentially driving up the stock's price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100